Search results

In our February 3rd blog, we discussed the difference between genetics and genomics. Today, we focus on the advances being made in medicine that are affected or influenced by the increased understanding of the human genome.

Discover how Altasciences reduced clinical trial start-up timelines by 70%, initiating the first dose of a Phase I MAD study in just 3.5 weeks.

Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.

Learn more about how Altasciences can test cognition, and the impact of driving under the influence of medication, using our state-of-the-art driving simulators.